These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2728404)

  • 21. Comparison of the antineuraminidase antibody response to vaccination with intact virus and subunit preparations obtained by different techniques of the influenza virus strains A/Sing/1/57 (H2N2), A/Hong Kong/1/68 (H3N2) and A/Port Chalmers/1/73 (H3N2).
    Drescher J; Desselberger U
    Comp Immunol Microbiol Infect Dis; 1980; 3(1-2):219-23. PubMed ID: 6162604
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
    Polezhaev FI; Budilovskiĭ GN; Garmashova LM; Romeĭko-Gurko IuR; Egorov AIu
    Vopr Virusol; 1983; 28(6):710-4. PubMed ID: 6670253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of the lectin test for detecting antineuraminidase antibodies in the sera of vaccinated subjects].
    Ivanova VT; Slepushkin AN; Burtseva EI; Balandin DI; Varecková E; Rudenko LG; Obrosova-Serova NP
    Vopr Virusol; 1991; 36(6):469-71. PubMed ID: 1785180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old].
    Grigor'eva EP; Rekstin AR; Rudenko LG; Ramirez A; Barro M; Lisovskaia KV; Klimov AI; Aleksandrova GI
    Vopr Virusol; 1994; 39(1):26-9. PubMed ID: 8160445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.
    Sugaya N; Nerome K; Ishida M; Matsumoto M; Mitamura K; Nirasawa M
    JAMA; 1994 Oct; 272(14):1122-6. PubMed ID: 7933325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.
    Pyhälä R
    J Hyg (Lond); 1985 Oct; 95(2):437-45. PubMed ID: 4067298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain.
    Mendelman PM; Rappaport R; Cho I; Block S; Gruber W; August M; Dawson D; Cordova J; Kemble G; Mahmood K; Palladino G; Lee MS; Razmpour A; Stoddard J; Forrest BD
    Pediatr Infect Dis J; 2004 Nov; 23(11):1053-5. PubMed ID: 15545863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14].
    Rudenko LG; Ramirez A; Barro M; Gushchina MI; Armanda RE; Ermachenko TA; Romanova IuR; Grigor'eva EP; Aleksandrova GI; Lonskaia NI
    Vopr Virusol; 1991; 36(6):472-4. PubMed ID: 1785181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of the immune response in children multiply inoculated with an inactivated influenza vaccine].
    Rudenko LG; Vasil'eva RI; Smirnova LA; Doroshenko EM
    Vopr Virusol; 1988; 33(4):407-11. PubMed ID: 3195142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of a study of collective immunity to influenza A virus (H1N1) from 1976 to 1980].
    Naĭkhin AN; Denisov GM; Ivannikov IuG; Lisok TP; Oleĭnikova EV
    Vopr Virusol; 1981; (5):553-7. PubMed ID: 7336683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses.
    Sonoguchi T; Naito H; Hara M; Takeuchi Y; Fukumi H
    J Infect Dis; 1985 Jan; 151(1):81-8. PubMed ID: 3965596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.
    Potter CW; Clark A; Jennings R; Schild GC; Wood JM; McWilliams PK
    J Biol Stand; 1980; 8(1):35-48. PubMed ID: 6995458
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses.
    Clover RD; Crawford S; Glezen WP; Taber LH; Matson CC; Couch RB
    J Infect Dis; 1991 Feb; 163(2):300-4. PubMed ID: 1988512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic memory to influenza A viruses in man determined by monovalent vaccines.
    Marine WM; Thomas JE
    Postgrad Med J; 1979 Feb; 55(640):98-104. PubMed ID: 461278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs.
    Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y
    Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal influenza vaccines, science fiction or soon reality?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.
    Wei CJ; Boyington JC; McTamney PM; Kong WP; Pearce MB; Xu L; Andersen H; Rao S; Tumpey TM; Yang ZY; Nabel GJ
    Science; 2010 Aug; 329(5995):1060-4. PubMed ID: 20647428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus.
    Powers DC; McElhaney JE; Florendo OA; Manning MC; Upshaw CM; Bentley DW; Wilkinson BE
    J Infect Dis; 1997 Feb; 175(2):342-51. PubMed ID: 9203655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.